Alii protected amino acida ad disulfide vinculum

NO

Productus

Cas non

Applicatio

Key species indicator

Pudicitia

Isomer

Specifica

* Max1

Humor

1

FMOC-CYS (ACM) -OH

86060-81-3

Disulfide vinculum

≥99.0%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

2

Fmoc-CYS (MMT) -OH

177582-21-7

Disulfide vinculum

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

3

Fmoc-cys (IV-allylbutyrate) -oh

/

Disulfide vinculum

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

4

MPA (TT) -OH

27144-18-9

Finis sequentia

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

5

Fmoc, Thr (TBU) -ol

189337-28-8

Octrotide

≥97.0%

≤0.3%

≤0.5%

≤1.0%

≤1.0%

6

Fmoc-D-Arg (PBF) -OH

187618-60-6

Desminopressin

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤2.0%

7

Fmoc-Gly-Gly-O

35665-38-4

Bivalirudin

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

8

FMOC-Gly-Gly-Gly-O

170941-79-4

Terlipressin

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

9

FMOC-Gly-Gly-Gly-Gly-O

/

Bivalirudin

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

10

Fmoc-Gly-ASP (TBU) -OH

/

Bivalirudin

≥99.5%

/

≤0.15%

≤0.2%

≤1.0%

11

Boc, CYS (TT) -OH

21947-98-8

Finis sequentia

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

12

Boc, Arg (PBF) -OH

200124-22-7

Finis sequentia

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

13

Boc-Ala

15761-38-3

Finis sequentia

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

14

Boc-D-Phe-O

18942-49-9

Finis sequentia

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

15

Boc-Gly-O

4530-20-5

Finis sequentia

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

16

Boc, Lys (Boc) -oh.dcha

15098-69-8

Finis sequentia

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

17

Boc, ser (TBU) -OH

7738-2222-9

Finis sequentia

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

18

Threum Boc (TBU) -OH

13734-40-2

Finis sequentia

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

19

Boc-D-ALA-O

7764-95-6

Finis sequentia

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

20

Boc-occurrit-O

2488-15-5

Finis sequentia

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

21

Boc-Tyr (TBU) -OH

47375-34-8

Finis sequentia

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

22

Boc-D-Arg (PDF) -OH

187618-60-6

Finis sequentia

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

23

Boc, ASP (OTBU) -H.DCHA

1913/12/8

Finis sequentia

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

24

Fmoc, homoarg (PBF) -OH

1159680-21-3

Eptifibatide

≥98.5%

≤0.2%

/

≤0.5%

≤2.0%

25

FMOC-ASP, OTBU

129460-09-9

Thymalfasin

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

26

Fmoc-Tyr (mihi) -oh

77128-72-4

Carbetocin

≥98.5%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

27

Fmoc-orn (Boc) -oh

109425-55-0

Atosiban

Omnipressin

Daptomycin

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤2.0%

28

Fmoc-D-Tyr (et) -OH

162502-65-0

Atosiban

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

29

Fmoc, ASP (Olle) -OH

146982-24-3

Melanotan

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

30

AC-NLE-O

15891-49-3

Melanotan

≥99.0%

/

≤0.3%

≤0.3%

≤1.0%

31

Fmoc, NLE-O

77284-32-3

Melanotan

AFAALOLONIDIDIDID

≥99.0%

/

≤0.3%

≤0.3%

≤1.0%

32

AC-Glu (otbu) -oh

84192-88-1

Argirelent

Acyll Octippeptide-III

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

33

AC-β-ala-o · dcha

/

ACETYL Tetrapeptide, V

≥99.0%

/

≤0.3%

≤0.3%

≤1.0%

34

Fmoc, ß, ALA-O

35737-10-1

ACETYL Tetrapeptide, V

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

35

Fmoc-Hyp (TBU) -OH

122996-47-8

Icatibant

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

36

FMOC-Tui-O

130309-35-2

Icatibant

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

37

Fmoc-D-tic-O

130309-33-0

Icatibant

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

38

Fmoc-Oic-O

130309-37-4

Icatibant

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

39

Boc-sar-O

13734-36-6

Saralasin

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

40

Fmoc-SAR-O

77128-70-2

Saralasin

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

41

Fmoc-Tyr (so3na) -oh.h2o

106864-37-3

Sincalide

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

42

Fmoc-D-ASP (OTBU) -OH

112883-39-3

Daptomycin

≥98.5%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

43

AC-ser (TBU) -OH

77285-09-7

AFAALOLONIDIDIDID

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

44

Boc, homocys (TT) -OH

201419-16-1

Depreotide

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

45

Fmoc, Homcys (TRT) -OH

167015-23-8

Depreotide

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

46

FMOC-DAB-O

161420-87-7

Serpens venenum

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%